To date, increasing evidences have demonstrated that variants of SCARB1 were associated with plasma lipid levels (14), carotid intimal medial thickness (15), insulin sensitivity (16), and risk of CHD (17). The gene discussed is SCARB1; the disease is coronary artery disorder.